Current Ratio of Rubius Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2022
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Rubius Therapeutics, Inc. quarterly Current Ratio in x history and change rate from 31 Mar 2019 to 31 Dec 2022.
- Rubius Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2022 was 4.52x, a 52% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Rubius Therapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2022 | 4.52x | -4.88x | -52% | 31 Dec 2022 |
| Q3 2022 | 5.22x | -4.32x | -45% | 30 Sep 2022 |
| Q2 2022 | 6.56x | -2.56x | -28% | 30 Jun 2022 |
| Q1 2022 | 8.23x | -0.08x | -0.97% | 31 Mar 2022 |
| Q4 2021 | 9.4x | +1.64x | +21% | 31 Dec 2021 |
| Q3 2021 | 9.54x | +1.26x | +15% | 30 Sep 2021 |
| Q2 2021 | 9.12x | +0.15x | +1.7% | 30 Jun 2021 |
| Q1 2021 | 8.31x | -2.32x | -22% | 31 Mar 2021 |
| Q4 2020 | 7.76x | -4.79x | -38% | 31 Dec 2020 |
| Q3 2020 | 8.28x | -7.4x | -47% | 30 Sep 2020 |
| Q2 2020 | 8.97x | -11.29x | -56% | 30 Jun 2020 |
| Q1 2020 | 10.63x | -8.86x | -45% | 31 Mar 2020 |
| Q4 2019 | 12.56x | 31 Dec 2019 | ||
| Q3 2019 | 15.68x | 30 Sep 2019 | ||
| Q2 2019 | 20.26x | 30 Jun 2019 | ||
| Q1 2019 | 19.49x | 31 Mar 2019 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.